Cargando…

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer

BACKGROUND: Lung cancer survivors have a high risk of developing second primary lung cancer (SPLC), but little is known about the survival impact of SPLC diagnosis. METHODS: We analyzed data from 138 969 patients in the Surveillance, Epidemiology, and End Results (SEER), who were surgically treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Eunji, Luo, Sophia J, Aredo, Jacqueline V, Backhus, Leah M, Wilkens, Lynne R, Su, Chloe C, Neal, Joel W, Le Marchand, Loïc, Cheng, Iona, Wakelee, Heather A, Han, Summer S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9002287/ https://www.ncbi.nlm.nih.gov/pubmed/34893871 http://dx.doi.org/10.1093/jnci/djab224

Ejemplares similares

Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study
por: Luo, Sophia J, et al.
Publicado: (2021)

Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked
por: Choi, Eunji, et al.
Publicado: (2023)

Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
por: Choi, Eunji, et al.
Publicado: (2023)

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
por: Aredo, Jacqueline V, et al.
Publicado: (2022)

Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer
por: Choi, Eunji, et al.
Publicado: (2021)

Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer
por: Su, Chloe C., et al.
Publicado: (2023)

Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes
por: Wu, Julie, et al.
Publicado: (2022)

Lung Cancer Survival Among Chinese Americans, 2000 to 2010
por: Gomez, Scarlett Lin, et al.
Publicado: (2016)

Relationship of driver oncogenes to long term pemetrexed response in non-small cell lung cancer
por: Liang, Ying, et al.
Publicado: (2014)

Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study
por: Moksud, Nafeesa, et al.
Publicado: (2021)

Advances in the Use of Targeted Therapies in the Management of Non–Small Cell Lung Cancer
por: Wakelee, Heather, et al.
Publicado: (2018)

Review of erlotinib in the treatment of advanced non-small cell lung cancer
por: Ganjoo, Kristen N, et al.
Publicado: (2007)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Eligibility for Lung Cancer Screening Among Women Receiving Screening for Breast Cancer
por: Titan, Ashley L., et al.
Publicado: (2022)

The impact of COVID-19 on cancer screening and treatment in older adults: The Multiethnic Cohort Study
por: Mak, Victoria P, et al.
Publicado: (2023)

The role of gender in non-small cell lung cancer: a narrative review
por: Baiu, Ioana, et al.
Publicado: (2021)

Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study
por: Park, Sungshim L., et al.
Publicado: (2017)

Diet Quality and Risk of Lung Cancer in the Multiethnic Cohort Study
por: Park, Song-Yi, et al.
Publicado: (2021)

Atopic allergic conditions and prostate cancer risk and survival in the Multiethnic Cohort study
por: Wang, Anqi, et al.
Publicado: (2023)

Performance of a rule-based semi-automated method to optimize chart abstraction for surveillance imaging among patients treated for non-small cell lung cancer
por: Byrd, Catherine, et al.
Publicado: (2022)

Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California
por: DeRouen, Mindy C., et al.
Publicado: (2018)

Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients
por: Hernandez, Brenda Y, et al.
Publicado: (2015)

Targeting BRAF‐Mutant Non‐Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy
por: Baik, Christina S., et al.
Publicado: (2017)

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non–Small-Cell Lung Cancer in the United States and Vietnam
por: Nguyen, Kim-Son H., et al.
Publicado: (2018)

Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case series
por: Myall, Nathaniel J., et al.
Publicado: (2021)

Association of Sepsis Mortality with Specific Cancer Sites and Treatment Type: The Multiethnic Cohort Study
por: Shvetsov, Yurii B., et al.
Publicado: (2021)

Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
por: Myall, Nathaniel J, et al.
Publicado: (2021)

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancer
por: Wong, Lye-Yeng, et al.
Publicado: (2023)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

BPA, Parabens, and Phthalates in Relation to Endometrial Cancer Risk: A Case–Control Study Nested in the Multiethnic Cohort
por: Sarink, Danja, et al.
Publicado: (2021)

Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex
por: Gram, Inger T, et al.
Publicado: (2020)

Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study
por: Gram, Inger T., et al.
Publicado: (2022)

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second- or third-line treatment of patients with EGFR wild-type advanced non-small cell lung cancer (ECOG-ACRIN 1512): a phase 2 randomised controlled trial
por: Neal, Joel W., et al.
Publicado: (2016)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

The characteristics and survival of second primary lung cancer after Hodgkin’s lymphoma: A comparison with first primary lung cancer using the SEER database
por: Lin, Ling, et al.
Publicado: (2023)

A brief report on the mutational landscape in non-small cell lung cancer of South Asian patients: Comparison at a US and an Indian Institution
por: Roy, Mohana, et al.
Publicado: (2022)

Impact of the Coronavirus Disease 2019 Pandemic on Global Lung Cancer Clinical Trials: Why It Matters to People With Lung Cancer
por: Basu Roy, Upal, et al.
Publicado: (2021)

Smoking related lung cancer mortality by education and sex in Norway
por: Hansen, Merethe S., et al.
Publicado: (2019)

PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
por: Smeltzer, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s58ovq7k0h0b08rnrtdnam759u